-
1
Continuous glucose monitors (CGMs) measure blood glucose levels continuously, aiding insulin dosage determination in type 1 diabetes.
-
2
CGMs are increasingly used by individuals with type 2 diabetes and those without diabetes, despite a lack of evidence for health improvement.
-
3
In type 2 diabetes, CGMs can help modify insulin dosages based on glucose patterns, but evidence for preventing complications is lacking.
-
4
CGM use may lead to stress and sleep disruption due to repeated notifications, and excessive focus on glucose values may detract from overall health.
-
5
For insulin-treated individuals, CGMs simplify management and reduce finger-stick testing, particularly for those at high risk of low blood glucose.